Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Ahokoski O et al. |
Pharmacokinetics of finrozole (MPV-2213ad), a novel selective aromatase inhibitor, in healthy men.
|
|
2 |
Eerola H et al. |
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).
|
|
3 |
Eerola H et al. |
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.
|
|
4 |
Grönroos T et al. |
Pharmacokinetics of (18F)FETNIM: a potential hypoxia marker for PET.
|
|
5 |
Hakanen A, Minn H. |
Kuvafuusiot yleistyvät sädehoidon annossuunnittelussa.
|
|
6 |
Jukkola A et al. |
Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer.
|
|
7 |
Kailajärvi M et al. |
Early effects of 5-fluorouracil, epirubicin and cyclophosphamide therapy on common laboratory tests.
|
|
8 |
Kankuri M et al. |
Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma - a phase II study.
|
|
9 |
Karsila-Tenovuo S et al. |
Disturbances in craniofacial morphology in children treated for solid tumors.
|
|
10 |
Kellokumpu-Lehtinen P et al. |
Palliatiivinen sädehoito - tehokas lievitys potilaan oireisiin.
|
|
11 |
Lehtiö K et al. |
Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with (15O)H2O and (18F)fluoroerythronitroimidazole PET.
|
|
12 |
Lilja AM et al. |
Short-term effects of radiotherapy on attention and memory performances in patients with brain tumors.
|
|
13 |
Lundin J et al. |
Omission of histologic grading from clinical decision making may result overuse of adjuvant therapies in breast cancer: Results from a nationwide study.
|
|
14 |
Maass M et al. |
Effectiveness of radiological image data compression .
|
|
15 |
Mac Manus MP et al. |
F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma.
|
|
16 |
MacManus M et al. |
Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.
|
|
17 |
Marttunen M B et al. |
A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy.
|
|
18 |
Marttunen MB et al. |
Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
|
|
19 |
Mattson K et al. |
Keuhkosyövän hoitosuositus.
|
|
20 |
Maula S et al. |
The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas.
|
|
21 |
Mouridsen H et al. |
Superior efficacy of letrozole (Femara) versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the international letrozole breast cancer group.
|
|
22 |
Nikkanen V. |
Neuroendokriiniset kasvaimet. Rajoittuneen syövän hoito.
|
|
23 |
Nikkola J et al. |
High collagenase-1 expressicorrelates with a favourable chemoimmunotherapy response in human metastatic melanoma.
|
|
24 |
Nuutinen J. |
Positron emission tomography (PET) in planning of cancer treatment and monitoring of treatment response.
|
|
25 |
Pyrhönen S. |
Syövän uudet hoitomuodot.
|
|
26 |
Pyrhönen S. |
Neuroendokriiniset kasvaimet. Levinneen pienisoluisen syövän hoito.
|
|
27 |
Pyrhönen S. |
Syövän täsmähoito - onko sellaista olemassa?
|
|
28 |
Salminen E. |
Antiestrogeenivaikutteiset lääkkeet hormoniherkän rintasyövän hoidossa.
|
|
29 |
Salminen E. |
Joskus paranna, usein lievitä, aina lohduta.
|
|
30 |
Salminen E, Ahokoski O. |
Ensilinjan hoito hormoniherkässä rintasyövässä.
|
|
31 |
Salminen E et al. |
Modulation of IgG and complement receptor expression of phagocytes in kidney cancer patients during treatment with interferon-alpha.
|
|
32 |
Salminen E, Mac Manus M. |
Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer.
|
|
33 |
Sundström J et al. |
Management of testicular cancer. 16 years` experience from Southwest Finland.
|
|
34 |
Sutinen E. et al. |
Biodistribution of (11C)methylaminoisobutyric acid, a tracer for PET studies on system A amino acid transport in vivo.
|
|
35 |
Teppo L et al. |
Risk of a new primary cancer among patients with lung cancer of different histological types.
|
|
36 |
Vuoristo M-S et al. |
Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
|
|
37 |
Välimäki MJ et al. |
Harvinainen, mutta usein hoidolla hallittava karsinoidikasvain.
|
|
38 |
Wiklund T et al. |
Huonoennusteisen rintasyövän intensiivinen liitännäishoito.
|